Literature DB >> 11489197

Uremic toxicity: urea and beyond.

T A Depner1.   

Abstract

Successful replacement of renal function with dialysis supports the concept that uremia is a toxic state resulting from accumulated solutes and that toxicity results from high concentrations of these solutes in body fluids. Dialyzer clearance of urea, a surrogate toxin, is the currently accepted best measure of dialysis and dialysis adequacy, but it is admittedly a compromise due to current lack of knowledge about and inability to measure more toxic solutes. This failure could be explained if uremic toxicity is actually a summation effect of multiple toxins, each at individual subtoxic levels in the patient. Other solutes could be used as surrogates to measure clearance, but urea happens to be available in high concentrations, is easily measured by all clinical laboratories, and is easily dialyzed, so changes in concentration are sensitive indicators of clearance. Measurements of creatinine clearance are confounded by the disequilibrium that occurs across red cells within the dialyzer and in the patient. Other solutes probably behave more like creatinine than urea, so urea stands out as uniquely diffusible, a property that actually spoils its effectiveness as a surrogate toxin, especially when applied to more frequent and continuous dialysis. Accumulation of other solutes may correlate better with toxic uremic symptoms and the residual syndrome. More studies are needed to examine the kinetics of other solutes, their generation rates, and their distribution volumes to provide clinicians with more knowledge and tools to optimize dialysis treatments. Examination of the effectiveness of solute removal in patients dialyzed more frequently may provide significant insight into the pathogenesis of uremia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489197     DOI: 10.1046/j.1525-139x.2001.00072.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  34 in total

1.  Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients.

Authors:  Tariq Shafi; Neil R Powe; Timothy W Meyer; Seungyoung Hwang; Xin Hai; Michal L Melamed; Tanushree Banerjee; Josef Coresh; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2016-07-19       Impact factor: 10.121

2.  Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.

Authors:  Tariq Shafi; Thomas H Hostetter; Timothy W Meyer; Seungyoung Hwang; Xin Hai; Michal L Melamed; Tanushree Banerjee; Josef Coresh; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2017-01-12       Impact factor: 8.860

3.  Self-Registration Methods for Increasing Membrane Utilization within Compression-Sealed Microchannel Hemodialysers.

Authors:  Brian K Paul; Spencer D Porter
Journal:  J Manuf Process       Date:  2014-10       Impact factor: 5.010

4.  Protein carbamylation predicts mortality in ESRD.

Authors:  Robert A Koeth; Kamyar Kalantar-Zadeh; Zeneng Wang; Xiaoming Fu; W H Wilson Tang; Stanley L Hazen
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

Review 5.  Searching for uremic toxins.

Authors:  Mirela Dobre; Timothy W Meyer; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

Review 6.  Approaches to uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

Review 7.  Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.

Authors:  David A Drew; Daniel E Weiner; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

8.  More with Less: A Trial of Reduced-Intensity Treatment in Transplant-Ineligible Hemodialysis Patients.

Authors:  Nathaniel Berman; M Carrington Reid; Jeanne Teresi; Joseph P Eimicke; Ronald Adelman
Journal:  J Palliat Med       Date:  2016-05       Impact factor: 2.947

9.  A zebrafish model for uremic toxicity: role of the complement pathway.

Authors:  Nathaniel Berman; Melisa Lectura; Josh Thurman; James Reinecke; Amanda C Raff; Michal L Melamed; James Reinecke; Zhe Quan; Todd Evans; Timothy W Meyer; Thomas H Hostetter
Journal:  Blood Purif       Date:  2013-05-08       Impact factor: 2.614

10.  Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.

Authors:  Simona Granata; Gianluigi Zaza; Simona Simone; Gaetano Villani; Dominga Latorre; Paola Pontrelli; Massimo Carella; Francesco Paolo Schena; Giuseppe Grandaliano; Giovanni Pertosa
Journal:  BMC Genomics       Date:  2009-08-21       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.